Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer. - Kao J; Genden EM; Chen CT; Rivera M; Tong CC; Misiukiewicz K; Gupta V; Gurudutt V; Teng M; Packer SH (Cancer (0008543X), 2011)